| Ytd | -77.47% | |
| 1y | -85.73% |
| Open | 0.33 | Prev Close | 0.32 | Low | 0.32 | High | 0.34 | Mkt Cap | 4.15M |
| Vol | 5.20K | Avg Vol | 59.45K | EPS | -1.45 | P/E | -0.22 | Forward P/E | -8.82 |
| Beta | 1.60 | Short Ratio | 0.70 | Inst. Own | 12.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-19 | 50-d Avg | 0.37 | 200-d Avg | 1.09 | 1yr Est | 12.50 |
CLGN News
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved upwards by 98.7% to $83.53 during Tues
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing i
REHOVOT, Israel, June 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerat
From mining to biotech, these companies are exploring strategic alternatives, including a sale, to u
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
REHOVOT, Israel, May 29, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerati
REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthe
Inhibrx Biosciences (NASDAQ: INBX - Get Free Report) and CollPlant Biotechnologies (NASDAQ: CLGN - G
REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
REHOVOT, Israel, March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
REHOVOT, Israel, March 18, 2026 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthet
CollPlant Biotechnologies (NASDAQ: CLGN - Get Free Report) and CG Oncology (NASDAQ: CGON - Get Free
REHOVOT, Israel, March 11, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
Intellectual Property Rights Secured in One of the Largest Target Markets for CollPlant's Product
BioFlex Enables Rapid Formulation of Tunable rhCollagen Bioinks with Enhanced Tissue-Mimetic Perform
Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in pat
REHOVOT, Israel, Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerati
Expansion of rhCollagen and BioInk raw material sales in North American territories expected through
REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
TuHURA Biosciences (NASDAQ: HURA - Get Free Report) and CollPlant Biotechnologies (NASDAQ: CLGN - Ge
-- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen
A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D
The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical r
On Wednesday, 807 companies reached new 52-week lows.